

Author: Singh Nishith Madan Ravi Gulley James L
Publisher: Future Science
ISSN: 2041-6792
Source: Clinical Investigation, Vol.3, Iss.7, 2013-07, pp. : 651-663
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Clinical predictors of survival in men with castration‐resistant prostate cancer
CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. :


Clinical predictors of survival in men with castration‐resistant prostate cancer
CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. :


Reply to clinical predictors of survival in men with castration‐resistant prostate cancer
CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. :


Methylselenocysteine preventing castration‐resistant progression of prostate cancer
THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. :


Role of Immunotherapy in Castration‐Resistant Prostate Cancer (CRPC)
BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. :